Verapamil Alternatives Compared
Verapamil | Aimovig | Emgality |
|
---|
Verapamil | Aimovig (erenumab) | Emgality (galcanezumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Verapamil can help regulate the heart rate and lower blood pressure and is used to treat certain heart conditions. Constipation is the most common side effect of verapamil and it may interact with... View more |
Prescription only
Aimovig is a prescription medicine that can be self-injected under the skin once a month to prevent migraine headaches in adults. Injection site reactions and constipation are the most common side... View more |
Prescription only
Emgality is an injectable medication that can be self-administered subcutaneously (under the skin) once monthly for the prevention of migraine in adults or during a cluster headache period when used... View more |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
Popular comparisons
|
|||||||||||||||||||||||
More about Verapamil | More about Aimovig (erenumab) | More about Emgality (galcanezumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Verapamil has an average rating of 7.6 out of 10 from a total of 180 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 16% reported a negative effect. |
Aimovig has an average rating of 5.0 out of 10 from a total of 614 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 45% reported a negative effect. |
Emgality has an average rating of 5.0 out of 10 from a total of 461 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: verapamil side effects in more detail. |
See also: Aimovig side effects in more detail. |
See also: Emgality side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all verapamil prices |
View all Aimovig prices |
View all Emgality prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Calan SR, Verelan, Verelan PM |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
12 hours |
672 hours |
648 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 646 drugs are known to interact with verapamil:
|
A total of 2 drugs are known to interact with Aimovig:
|
A total of 2 drugs are known to interact with Emgality:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
March 08, 1982 |
May 17, 2018 |
September 27, 2018 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.